$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
靶向药阿伐曲泊帕(Doptelet)的中文说明书
2025-10-19 11:44:20
Check Details
阿伐曲泊帕(Doptelet)的用法用量:用药指南,剂量调整,特殊人群用药,用药注意事项
2025-10-19 11:44:20
Check Details
FDA批准阿伐曲泊帕(Doptelet)用于治疗1岁及以上持续性或慢性免疫性血小板减少症(ITP)儿科患者的血小板减少症
2025-10-19 11:44:20
Check Details
FDA批准阿伐曲泊帕(Doptelet)用于治疗慢性免疫性血小板减少症(ITP)
2025-10-19 11:44:20
Check Details
FDA批准阿伐曲泊帕(Doptelet)用于治疗需接受医疗手术的慢性肝病合并血小板减少症患者
2025-10-19 11:44:20
Check Details
阿伐曲泊帕(Doptelet)的副作用:严重不良反应,常见副作用,副作用管理
2025-10-19 11:44:20
Check Details
靶向药阿伐曲泊帕(Doptelet),苏可欣,Avatrombopag的详细说明书
2025-10-19 11:44:20
Check Details
艾曲波帕(eltrombopag)纳入医保了吗?
2025-10-19 11:44:20
Check Details
阿伐曲泊帕(Doptelet)在国内上市了吗?
2025-10-19 11:44:20
Check Details
阿伐曲泊帕(Doptelet)纳入医保了吗?
2025-10-19 11:44:20
Check Details
艾曲波帕(eltrombopag)在国内上市了吗?
2025-10-19 11:44:20
Check Details
普鲁士蓝胶囊用法用量?
2025-10-19 11:44:20
Check Details
1
2
...
5198
5199
5200
5201
5202
5203
5204
...
10205
10206
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Ceritinib Capsule Storage Conditions & Expiration Guide: Room Temperature Storage, No Refrigeration Needed
2
Selumetinib for NF1 Treatment: Complete Guide to Targeted Therapy for Type 1 Neurofibromatosis
3
Enasidenib Targeted Therapy Guide: IDH2 Mutant AML Patient Medication Details
4
Anagrelide Medication Guide: Dosage, Efficacy and Side Effects Explained
5
RAS Targeted Therapy Resistance Breakthrough: mTORC1 is Key, Dalifarnib Combination Therapy Brings Hope
6
ARID1A Gene: A New Breakthrough in Tumor Immunotherapy, Turning "Cold Tumors" Hot
7
Alectinib for ALK-Positive Lung Cancer: Efficacy, Side Effects & Clinical Outlook
8
Mavacamten (Maifantuo): A Targeted Therapy for Obstructive Hypertrophic Cardiomyopathy
9
Remibrutinib (Ruipoduo): Safety, Side Effects, and Usage Guidelines
10
Which Generation TKI Is Repotrectinib? Professional Analysis of Next-Gen ROS1 Inhibitor Classification and Clinical Features
11
Brigatinib for NF2 Neurofibromatosis: Mechanism, Efficacy and Prospects
12
Dietary Guide During Goserelin Treatment: Scientific Nutrition Management to Alleviate Side Effects and Improve Quality of Life.